Harlan Krumholz, Contributor

Author's posts

Hydroxychloroquine And Azithromycin For COVID-19: Benefits TBD, Risks Clear

In the midst of a pandemic, lots of people have ideas for cures. We are desperate for therapies and the virus can be deadly. The problem is that the presumptive cure can add danger to the disease, rather than mitigate it.

COVID-19: Who Is Infectious?

The current approach in the US is to screen an sequester people who are sick. But I think this approach is folly if we think it will do enough to break the chain of virus transmission.

Why A Heart Attack Should Not Disqualify Someone From Being President

For many people, a heart attack today need not be disqualifying for ultimately engaging in even the most vigorous activities – and that includes fulfilling the duties of the Presidency. The key is to employ all that can be done to reduce future risk.

Aspirin: Have The New Guidelines Changed What You Should Do?

For many people without evidence of cardiovascular disease, less will be more – with the benefit of aspirin just not worth the risk and inconvenience – and that is particularly true for those older than 70 years or with an increased risk of bleeding. A…

The Unfortunate Truth About Getting Your Medical Records

My family’s experience – and those of many others – led our research team at Yale to publish about the experience of people seeking to obtain their medical records. The story reveals an unfortunate truth about getting your medical records in America….

News For Healthy, Older Patients: Toss Your Baby Aspirin

A study found that an enteric-coated, aspirin that is similar to the dose of a baby aspirin increased the risk of death, did not reduce the risk of heart disease or disability or dementia or cancer